Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosisMai Nguyen, Richard C Marcellus, Anne Roulston, et al.Pharmacogenetics and Genomics|October 8, 2009
Post-treatment tumor gene expression signatures are more predictive of treatment outcomes than baseline signatures in breast cancerSoo-Chin Lee, Xin Xu, Wee-Joo Chng, et al.NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.Research Square|February 12, 2026
Senescence-Linked Fibrosis in the Aging Human Ovary Revealed by p16-Based Histological Profiling and Spatial TranscriptomicsBirgit Schilling, Mark Watson, Pooja Devrukhkar, et al.Nature|February 23, 2010
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis CJacques Fellay, Alexander J Thompson, Dongliang Ge, et al.Journal of Medical Genetics|June 28, 2022
Uncovering the burden of hidden ciliopathies in the 100 000 Genomes Project: a reverse phenotyping approachSunayna Best, Jing Yu, Jenny Lord, et al.Cell Reports|June 20, 2024
A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccineAdam-Nicolas Pelletier, Gabriela Pacheco Sanchez, Abdullah Izmirly, et al.Oxford Open Immunology|January 23, 2026
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patientsNicola Principe, Kofi L P Stevens, Amber-Lee Phung, et al.Frontiers in Immunology|December 2, 2020
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint TherapyNicola Principe, Joel Kidman, Siting Goh, et al.Nature Communications|August 10, 2016
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancersChristopher A Miller, Yevgeniy Gindin, Charles Lu, et al.Pageof 13